Chapter Three - Gamma-Glutamyl Transpeptidase: Redox Regulation and Drug Resistance
Introduction
In 1985, gamma-glutamyl transpeptidase (GGT, aka gamma-glutamyl transferase) was first proposed to play a role in tumor formation (Hanigan & Pitot, 1985b). Preneoplastic liver foci in rats treated with chemical carcinogens were identified by their expression of GGT (Goldsworthy, Hanigan, & Pitot, 1986). We proposed that the expression of GGT provided the cells within the foci a selective growth advantage during the promotion phase of carcinogenesis (Hanigan & Pitot, 1985b). This hypothesis was based on the observation that the treatment regimens, which gave rise to GGT-positive liver foci, all included promoting compounds that depleted glutathione (GSH). The hypothesis was that GGT, which is localized to the cell surface, cleaved extracellular GSH, thereby providing the cell with the amino acids necessary for intracellular GSH synthesis. GGT activity enabled the cells to maintain their intracellular GSH levels, thus resisting the toxicity of the promoting compounds and enabling them to respond to the proliferative signals triggered by the carcinogenic regimen. Now, decades later, there is a great deal of new information about the enzyme that supports this hypothesis. These data will be reviewed in this chapter. Further, studies from many laboratories have demonstrated that this same mechanism, through which GGT was proposed to contribute to the preneoplastic cell's resistance to the toxicity of promoting agents, also confers GGT-positive tumors with resistance to prooxidant anticancer therapy. GGT enhances the tumor's access to cysteine, thereby increasing the intracellular GSH level. This enables the tumors to maintain their redox balance during the onslaught of reactive oxygen species (ROS) generated by the prooxidant anticancer therapies and to avoid death via the cell death pathways triggered by oxidative stress. Clinical studies have shown a correlation between GGT expression in human tumors and their resistance to therapy. Studies in cell culture and data from animal models have provided information on the signaling and regulatory pathways that underlie this correlation. To understand the relationship between GGT expression and drug resistance, it is necessary to first understand the role of GGT in normal physiology. This chapter will review the current information about GGT and its role in redox regulation, its expression in tumors, its induction by toxins including many of the most commonly used chemotherapy agents, and a strategy to use GGT inhibitors to overcome the resistance of both GGT-positive and GGT-negative tumors to prooxidant anticancer therapy.
Section snippets
Expression of GGT and Drug Resistance in Human Tumors
Clinical studies show a strong correlation between the expression of GGT in tumors and poor survival. Our study of 451 human tumors prior to treatment showed that GGT is induced during the development of many tumors (Hanigan, Frierson, Swanson, & De Young, 1999). Tumors derived from ductal epithelial cells that normally express GGT were generally strongly GGT-positive (Hanigan & Frierson, 1996). These include liver, renal, prostatic, pancreatic, and breast carcinomas (Table 3.1). Due to the
Structure of GGT
In eukaryotes, GGT is a cell surface glycoprotein. It is anchored in the cell membrane via a single N-terminus transmembrane domain. All of the catalytic activity is within the extracellular domain of the protein (Ikeda, Fujii, Taniguchi, & Meister, 1995). Human GGT is synthesized as a 569 amino acid propeptide (Rajpert-De Meyts, Heisterkamp, & Groffen, 1988). The propeptide is enzymatically inactive, but is activated by autocleavage into two subunits (West et al., 2010, West et al., 2011). The
Biochemistry of GGT-Catalyzed Reactions
GGT is localized to the cell surface and only cleaves extracellular substrates. GSH and oxidized GSH (GSSG) are the most abundant physiological substrates, although GGT cleaves any gamma-glutamyl substrate including GSH S-conjugates (Wickham, West, Cook, & Hanigan, 2011). The substrate glutamate moiety must be unrestricted except for the gamma-glutamyl bond (Fig. 3.2). GGT will not cleave gamma-glutamyl bonds formed with glutamate that is within a peptide or with glutamate bound to any other
In normal tissues and in tumors
GGT is expressed on the luminal surface of excretive and absorptive cells that line glands and ducts throughout the body, with the highest level of GGT activity in the kidney (Hanigan & Frierson, 1996). The development of strains of GGT knockout mice revealed the role of GGT in the distribution of cysteine throughout the body (Harding et al., 1997, Lieberman et al., 1996, Yamada et al., 2013). GGT knockout mice excrete 2500-fold more GSH in their urine than wild-type mice (Lieberman et al., 1996
GSH and intracellular redox regulation
GSH is the most abundant nonprotein thiol in mammalian systems and the major redox buffer in the cell (Moriarty-Craige & Jones, 2004). GSH protects cellular components from oxidative damage of ROS, such as hydrogen peroxide and organic peroxides via GSH peroxidases, and also detoxifies the electrophilic metabolites of toxins, including chemotherapy drugs (Moriarty-Craige & Jones, 2004) (Fig. 3.4). The ratio of oxidized GSH (GSSG) to 2GSH can be used as a measure of the intracellular redox
The Role of GGT in Enhancing Cysteine Availability and Drug Resistance
A dramatic shift in the availability of cysteine occurs when GGT-positive cells are depolarized or GGT is induced in GGT-negative cells. Under these conditions, GGT is no longer restricted to substrates present in the fluids within ducts and glands as it is in normal tissues, but now can cleave both oxidized and reduced GSH in interstitial fluid, providing the cell access to the cystine and cysteine therein. Cameron et al. reported that in rats with neoplastic liver nodules and carcinomas, GSH
Redox Regulation of GGT
Expression of GGT and its role in redox regulation have been studied extensively in rats, mice, and humans. However, there are differences in the expression and regulation of GGT among these species that are often not recognized, but provide insight into GGT regulation and function. Therefore, we will consider the data from each species separately.
Overcoming Resistance to Prooxidant Anticancer Therapy by Inhibiting GGT
Reducing the intracellular GSH concentration sensitizes tumors to many diverse chemotherapy drugs (Butturini et al., 2013, Calvert et al., 1998, Estrela et al., 2006, Hamaguchi et al., 1993, Maciag et al., 2013, Ortega et al., 2011, Ruoso and Hedley, 2004, Traverso et al., 2013) (Crook, Souhami, Whyman, & McLean, 1986). To date, two different approaches have been evaluated clinically to try to reduce the synthesis of intracellular GSH. Sulfasalazine, a drug that blocks the cystine transporter
Summary
Expression of GGT is essential in maintaining the cysteine levels in the body. Induction of GGT expression in response to redox stress provides the cell with access to additional cysteine, which becomes rate-limiting for intracellular GSH synthesis. Our understanding of the role of GGT in redox regulation and its induction in cells under redox stress will aid in the development of new anticancer therapies. GGT first came to the attention of cancer researchers as a biomarker for preneoplastic
Acknowledgments
We gratefully acknowledge Dr. Stephanie Wickham's assistance in preparing Fig. 3.3. This work was supported in part by the National Institutes of Health Grants P20GM103640 (an Institutional Development Award (IDeA)).
References (181)
- et al.
Direct evidence for inter-organ transport of glutathione and that the non-filtration renal mechanism for glutathione utilization involves gamma-glutamyl transpeptidase
Biochemical and Biophysical Research Communications
(1980) - et al.
Celecoxib pre-treatment in human colorectal adenocarcinoma patients is associated with gene expression alterations suggestive of diminished cellular proliferation
European Journal of Cancer
(2008) - et al.
Glutathione transporters
Biochimica et Biophysica Acta
(2013) - et al.
Increased expression of gamma-glutamyl transpeptidase in transfected tumor cells and its relationship to drug sensitivity
Cancer Letters
(1994) - et al.
Acceleration of glutathione efflux and inhibition of gamma-glutamyltranspeptidase sensitize metastatic B16 melanoma cells to endothelium-induced cytotoxicity
The Journal of Biological Chemistry
(2005) - et al.
Metabolism of glutathione; hydrolysis by tissues of the rat
The Journal of Biological Chemistry
(1948) - et al.
Diurnal variation in glutathione and cysteine redox states in human plasma
The American Journal of Clinical Nutrition
(2007) - et al.
Functional characterization of the rat gamma-glutamyl transpeptidase promoter that is expressed and regulated in the liver and hepatoma cells
The Journal of Biological Chemistry
(1994) - et al.
Mild oxidative stress induces S-glutathionylation of STAT3 and enhances chemosensitivity of tumoral cells to chemotherapeutic drugs
Free Radical Biology and Medicine
(2013) - et al.
Clinical studies of reversal of drug resistance based on glutathione
Chemico-Biological Interactions
(1998)
gamma-Glutamyl leukotrienase, a gamma-glutamyl transpeptidase gene family member, is expressed primarily in spleen
The Journal of Biological Chemistry
Cataract development in gamma-glutamyl transpeptidase-deficient mice
Experimental Eye Research
Gamma-glutamyl transpeptidase gene organization and expression: A comparative analysis in rat, mouse, pig and human species
Comparative Biochemistry and Physiology. Part B, Biochemistry and Molecular Biology
Reactive oxygen species, cellular redox systems, and apoptosis
Free Radical Biology & Medicine
Transport of glutathione and glutathione conjugates by MRP1
Trends in Pharmacological Sciences
Enzymes involved in processing glutathione conjugates
Membrane gamma-glutamyl transferase activity promotes iron-dependent oxidative DNA damage in melanoma cells
Mutation Research
Differential regulation of gamma-glutamyltransferase mRNAs in four human tumour cell lines
Biochimica et Biophysica Acta
Plasma glutathione and cystathionine concentrations are elevated but cysteine flux is unchanged by dietary vitamin B-6 restriction in young men and women
The Journal of Nutrition
The 5' untranslated region of the human gamma-glutamyl transferase mRNA contains a tissue-specific active translational enhancer
FEBS Letters
Redox modulation of cell surface protein thiols in U937 lymphoma cells: The role of gamma-glutamyl transpeptidase-dependent H2O2 production and S-thiolation
Free Radical Biology & Medicine
Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes
Genomics
Divergence and convergence in enzyme evolution
The Journal of Biological Chemistry
Metabolism and action of amino acid analog anti-cancer agents
Pharmacology & Therapeutics
Altered expression of gamma-glutamyl transpeptidase in human tumors
Human Pathology
Expression of gamma-glutamyl transpeptidase in stage III and IV ovarian surface epithelial carcinomas does not alter response to primary cisplatin-based chemotherapy
American Journal of Obstetrics and Gynecology
Gamma-glutamyl transpeptidase-deficient mice are resistant to the nephrotoxic effects of cisplatin
The American Journal of Pathology
Mice with genetic gamma-glutamyl transpeptidase deficiency exhibit glutathionuria, severe growth failure, reduced life spans, and infertility
The Journal of Biological Chemistry
CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(−) and thereby promotes tumor growth
Cancer Cell
gamma -glutamyltransferase and its isoform mediate an endoplasmic reticulum stress response
The Journal of Biological Chemistry
Role of CYP2E1 in thioacetamide-induced mouse hepatotoxicity
Toxicology and Applied Pharmacology
The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer
Redox Biology
Expression of gamma-glutamyl transpeptidase protects ramos B cells from oxidation-induced cell death
The Journal of Biological Chemistry
Gamma-glutamyl transpeptidase substrate specificity and catalytic mechanism
Methods in Enzymology
A novel, species-specific class of uncompetitive inhibitors of gamma-glutamyl transpeptidase
The Journal of Biological Chemistry
Electrophoretic fractionation of serum gamma-glutamyl transpeptidase in human hepatic cancer
Clinica Chimica Acta
Nitric oxide-releasing prodrug triggers cancer cell death through deregulation of cellular redox balance
Redox Biology
gamma-Glutamyl transpeptidase (gamma-GT) and maintenance of thiol pools in tumor cells resistant to alkylating agents
Journal of Cellular Physiology
Glutathione-dependent bioactivation of haloalkenes
Annual Review of Pharmacology and Toxicology
Phase I study of continuous-infusion L-S, R-buthionine sulfoximine with intravenous melphalan
Journal of the National Cancer Institute
The role of glutathione in cancer
Cell Biochemistry and Function
gamma-Glutamyltranspeptidase activity in human breast lesions: An unfavourable prognostic sign
British Journal of Cancer
Oxygen-induced pulmonary injury in gamma-glutamyl transpeptidase-deficient mice
Lung
CD44 staining of cancer stem-like cells is influenced by down-regulation of CD44 variant isoforms and up-regulation of the standard CD44 isoform in the population of cells that have undergone epithelial-to-mesenchymal transition
PLoS One
A protein catalytic framework with an N-terminal nucleophile is capable of self-activation
Nature
Regulation of cancer cell metabolism
Nature Reviews. Cancer
Utilization of circulating glutathione by nodular and cancerous intact rat liver
Carcinogenesis
Kinetic characterization and identification of the acylation and glycosylation sites of recombinant human gamma-glutamyltranspeptidase
Biochemistry
Distinct redox profiles of selected human prostate carcinoma cell lines: Implications for rational design of redox therapy
Cancers
Roles of reactive oxygen species in the fate of stem cells
Antioxidants & Redox Signaling
Cited by (196)
Recent advances in enzyme-activated NIR fluorescent probes for biological applications
2023, TrAC - Trends in Analytical ChemistryTargeting gamma-glutamyl transpeptidase: A pleiotropic enzyme involved in glutathione metabolism and in the control of redox homeostasis
2023, Free Radical Biology and MedicineSAR of L-ABBA analogs for GGT1 inhibitory activity and L-ABBA's effect on plasma cysteine and GSH species
2023, Bioorganic and Medicinal Chemistry Letters